BFS
TGTX icon

Bare Financial Services’s TG Therapeutics TGTX Stock Holding History

Bare Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9K Buy
398
+172
+76% +$7.04K 0.01% 242
2026
Q1 		$7.51K Buy
226
+50
+28% +$1.49K ﹤0.01% 482
2025
Q4 		$5.25K Sell
176
-27
-13% -$882 ﹤0.01% 521
2025
Q3 		$7.33K Buy
203
+7
+4% +$231 ﹤0.01% 365
2025
Q2 		$7.05K Buy
196
+138
+238% +$5.14K ﹤0.01% 305
2025
Q1 		$2.29K Buy
+58
New +$1.95K ﹤0.01% 229

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Bare Financial Services's TGTX Position: Q2 2026 in Review

Bare Financial Services increased its TG Therapeutics (TGTX) stake by 76% in Q2 2026, buying an estimated $7.04K and bringing the position to 398 shares worth $21.9K. The position accounts for 0.01% of the portfolio, ranked #242.

Bare Financial Services first reported a position in TGTX in Q1 2025 and has held it in 6 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Bare Financial Services held 398 shares of TG Therapeutics worth $21.9K as of Q2 2026.
  • Bare Financial Services bought 172 TG Therapeutics shares in Q2 2026, an estimated $7.04K.
  • TG Therapeutics made up 0.01% of Bare Financial Services's portfolio in Q2 2026, its #242 holding.
  • Bare Financial Services first reported a position in TG Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.